Selected research
Market Structure
Global Enasidenib Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Enasidenib Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Enasidenib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Enasidenib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Enasidenib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Enasidenib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Enasidenib Drugs include Bristol Myers Squibb. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Enasidenib Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Enasidenib Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Enasidenib Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enasidenib Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Enasidenib Drugs Segment by Company
Bristol Myers Squibb
Enasidenib Drugs Segment by Type
50mg
100mg
Enasidenib Drugs Segment by Application
Hospital
Pharmacy
Enasidenib Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enasidenib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enasidenib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enasidenib Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Enasidenib Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enasidenib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enasidenib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Enasidenib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 50mg
- 100mg
Applications
- Hospital
- Pharmacy
Companies covered
- Bristol Myers Squibb
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Enasidenib Drugs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Enasidenib Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Enasidenib Drugs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Enasidenib Drugs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Enasidenib Drugs Market Dynamics
- 2.1 Enasidenib Drugs Industry Trends
- 2.2 Enasidenib Drugs Industry Drivers
- 2.3 Enasidenib Drugs Industry Opportunities and Challenges
- 2.4 Enasidenib Drugs Industry Restraints
3 Enasidenib Drugs Market by Manufacturers
- 3.1 Global Enasidenib Drugs Revenue by Manufacturers (2021-2026)
- 3.2 Global Enasidenib Drugs Sales by Manufacturers (2021-2026)
- 3.3 Global Enasidenib Drugs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Enasidenib Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Enasidenib Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Enasidenib Drugs Manufacturers, Product Type & Application
- 3.7 Global Enasidenib Drugs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Enasidenib Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Enasidenib Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Enasidenib Drugs Tier 1, Tier 2, and Tier 3
4 Enasidenib Drugs Market by Type
- 4.1 Enasidenib Drugs Type Introduction
- 4.1.1 50mg
- 4.1.2 100mg
- 4.2 Global Enasidenib Drugs Sales by Type
- 4.2.1 Global Enasidenib Drugs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Enasidenib Drugs Sales by Type (2021-2032)
- 4.2.3 Global Enasidenib Drugs Sales Market Share by Type (2021-2032)
- 4.3 Global Enasidenib Drugs Revenue by Type
- 4.3.1 Global Enasidenib Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Enasidenib Drugs Revenue by Type (2021-2032)
- 4.3.3 Global Enasidenib Drugs Revenue Market Share by Type (2021-2032)
5 Enasidenib Drugs Market by Application
- 5.1 Enasidenib Drugs Application Introduction
- 5.1.1 Hospital
- 5.1.2 Pharmacy
- 5.2 Global Enasidenib Drugs Sales by Application
- 5.2.1 Global Enasidenib Drugs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Enasidenib Drugs Sales by Application (2021-2032)
- 5.2.3 Global Enasidenib Drugs Sales Market Share by Application (2021-2032)
- 5.3 Global Enasidenib Drugs Revenue by Application
- 5.3.1 Global Enasidenib Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Enasidenib Drugs Revenue by Application (2021-2032)
- 5.3.3 Global Enasidenib Drugs Revenue Market Share by Application (2021-2032)
6 Global Enasidenib Drugs Sales by Region
- 6.1 Global Enasidenib Drugs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Enasidenib Drugs Sales by Region (2021-2032)
- 6.2.1 Global Enasidenib Drugs Sales by Region (2021-2026)
- 6.2.2 Global Enasidenib Drugs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Enasidenib Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Enasidenib Drugs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Enasidenib Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Enasidenib Drugs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Enasidenib Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Enasidenib Drugs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Enasidenib Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Enasidenib Drugs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Enasidenib Drugs Revenue by Region
- 7.1 Global Enasidenib Drugs Revenue by Region
- 7.1.1 Global Enasidenib Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Enasidenib Drugs Revenue by Region (2021-2026)
- 7.1.3 Global Enasidenib Drugs Revenue by Region (2027-2032)
- 7.1.4 Global Enasidenib Drugs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Enasidenib Drugs Revenue (2021-2032)
- 7.2.2 North America Enasidenib Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Enasidenib Drugs Revenue (2021-2032)
- 7.3.2 Europe Enasidenib Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Enasidenib Drugs Revenue (2021-2032)
- 7.4.2 Asia-Pacific Enasidenib Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Enasidenib Drugs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Enasidenib Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Bristol Myers Squibb
- 8.1.1 Bristol Myers Squibb Company Information
- 8.1.2 Bristol Myers Squibb Business Overview
- 8.1.3 Bristol Myers Squibb Enasidenib Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Bristol Myers Squibb Enasidenib Drugs Product Portfolio
- 8.1.5 Bristol Myers Squibb Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Enasidenib Drugs Value Chain Analysis
- 9.1.1 Enasidenib Drugs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Enasidenib Drugs Production Mode & Process
- 9.2 Enasidenib Drugs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Enasidenib Drugs Distributors
- 9.2.3 Enasidenib Drugs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst